Sweet Earth Holdings has launched its campaign on the Investing News Network’s cannabis channel.

Sweet Earth Holdings is a vertically-integrated hemp and CBD company cultivating its high-quality products from farms in Applegate Valley, Oregon. The company uses sustainable farming practices without the use of pesticides, herbicides, or chemical fertilizers. By keeping its crop batches small, Sweet Earth Holdings has been able to offer high-quality products that are carefully cultivated using sustainably-sources ingredients.


Sweet Earth Holdings has developed its own collection of proprietary strains at its cultivation facility in Oregon where the natural climate allows for optimal hemp growth. The company uses state-of-the-art greenhouses to ensure its crops return the highest quality. Through the selective breeding of the company’s own genetics, Sweet Earth has developed a 15 percent CBD strain including 1.27 percent CBN and 1.3 percent CBG.

Sweet Earth Holdings’ company highlights include the following:

  • Operates a 100-acre hemp cultivation facility in Appleton, Oregon
  • Facility includes six greenhouses encompassing 30,000 square feet of space designed for selective hemp breeding, planting and R&D
  • US CBD market project to grow at a CAGR of 22.2 percent from 2018 through 2025
  • Sweet Earth has developed over 10 different CBD-based body and skincare products
  • Developing a line of CBD pet products, including several flavors of CBD dog treats
  • Pursuing a diversified approach to distribution including ecommerce sales, retail sales, white label services and wholesale B2B distribution
  • Product ambassador and sponsor Warren Moon is a proponent of CBD and its remedial benefits, specifically the Sweet Earth line
  • CEO Peter Espig, an experienced Wall Street and Goldman Sachs executive, brings global capital market experience to Sweet Earth team

Click here to connect with Sweet Earth Holdings and to request an investor presentation.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less